PAOLA-1
OLAP+BEVA vs PLB+BEVA
L1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
First author: I. Ray‑Coquard
PRIMA GOG3012
NIRA vs PLB
L1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
First author: A. Gonzalez-Martín
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
VELIA GOG3005
VELI+chem...VELI vs PLB+chem...PLB
L1
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
First author: R.L. Coleman
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
First author: Jonathan Ledermann